Efficacy and Safety of IDH Inhibitors in AML: A Systematic Review of Clinical Trials

Autor: Ali, Muhammad Ashar ^*, Fatima, Shadma ^*, Nepal, Ashish ^*, Khan, Huda ^*, Bhatti, Mahak Khadija ^*, Saeed, Memoona ^*, Niaz, Rabiya ^*, Habib, Rooma ^*, Omar, Zainab ^*, Shafique, Zubair ^*, Khan, Muhammad Imran ^*, Hassab, Muhammad ^*, Aiman, Wajeeha ^*

Publikováno v: In Blood 15 November 2022 140 Supplement 1:11763-11764

Efficacy and Safety of Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma: A Systematic Review of Clinical Trials.

Autor: Farrukh M; Sir Syed College of Medical Sciences for Girls, Karachi, Pakistan., Ali MA; Sir Syed College of Medical Sciences for Girls, Karachi, Pakistan.; PHCC at St. Clare's and St. Mary's General Hospital, Denville, NJ, USA., Naveed M; Sir Syed College of Medical Sciences for Girls, Karachi, Pakistan.; Baqai Medical University, Karachi, Pakistan., Habib R; Baqai Medical University, Karachi, Pakistan., Khan H; University of Southern California, Los Angeles, CA, USA., Kashif T; Dow University of Health Sciences, Karachi, Pakistan., Zubair H; Rawalpindi Medical University, Rawalpindi, Pakistan., Saeed M; King Edward Medical University, Lahore, Pakistan., Butt SK; Fatima Jinnah Medical College, Lahore, Pakistan., Niaz R; King Edward Medical University, Lahore, Pakistan., Garg I; Fraser Health Authority, Surrey, Canada., Fatima A; Allama Iqbal Medical College, Lahore, Pakistan., Aiman W; Saint Michael's Medical Center, New York College of Medicine, Newark, NJ, USA.

Publikováno v: Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2023 Apr 04; Vol. 16 (3), pp. 170-185. Date of Electronic Publication: 2023 Apr 04.